Tubuva - Company finances
|
EUR
|
2018
From: 2018-08-10
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 533,457 | 6,337,373 | 4,185,202 | 1,384,198 | 2,415,403 | 2,224,160 | 2,975,480 |
| Profit before tax | 0 | -1,803 | 1,030,692 | -15,620 | -277,471 | 91,214 | 116,985 | - |
| Net profit | 0 | -1,803 | 876,088 | -15,620 | -277,471 | 87,076 | 111,325 | 198,558 |
| Equity | 2,500 | 2,500 | 876,786 | 508,224 | 199,291 | 295,133 | 414,881 | 613,439 |
| Liabilities | 0 | 108,706 | 1,093,249 | 1,288,671 | 237,284 | 796,127 | 532,052 | 882,467 |
| Non-current assets | 0 | 0 | 0 | 17,774 | 14,650 | 64,790 | 51,410 | 41,413 |
| Current assets | 2,500 | 111,206 | 1,970,035 | 1,778,731 | 416,730 | 1,009,090 | 860,399 | 1,414,859 |
| Total assets | 2,500 | 111,206 | 1,970,035 | 1,796,505 | 431,380 | 1,073,880 | 911,809 | 1,456,272 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 6,131 | 3,037 | 10,155 |
| Social insurance contributions | - | - | - | - | - | - | 1,308 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +1088.0% | -34.0% | -66.9% | +74.5% | -7.9% | +33.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -1.6% | 44.5% | -0.9% | -64.3% | 8.1% | 12.2% | 13.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -72.1% | 99.9% | -3.1% | -139.2% | 29.5% | 26.8% | 32.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -0.3% | 13.8% | -0.4% | -20.0% | 3.6% | 5.0% | 6.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -0.3% | 16.3% | -0.4% | -20.0% | 3.8% | 5.3% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 43.5 | 1.2 | 2.5 | 1.2 | 2.7 | 1.3 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 457,236 | 2,304,499 | 881,095 | 338,990 | 966,161 | 1,334,469 | 2,975,480 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tubuva - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-09-16 | 2021-09-26 | 18.03 |
Tubuva - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-21 | 2026-06-30 | 4.48 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tubuva, UAB (company code 304893235) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €2.98M and net profit of €198.6K, with a profit margin of 6.7%. Revenue increased by 33.8% year on year, and by 23.2% over two years, showing a clear upward trend after the 2024 decline. Net profit also improved materially from €87.1K in 2023 and €111.3K in 2024 to €198.6K in 2025, indicating stronger operating performance and better profitability. The balance sheet expanded in 2025, with total assets rising to €1.46M from €911.8K in 2024, while equity increased to €613.4K and liabilities to €882.5K. The equity ratio stood at 42.1%, and debt-to-equity was 1.44. Returns remained solid, with ROE at 32.4% and ROA at 13.6%. Asset turnover reached 2.04x, and revenue per employee was €2.98M, suggesting high productivity based on the latest available staff-related metric.